|View printer-friendly version|
|January 23, 2006 1:24 p.m.|
|U.S. Federal Trade Commission Clears Teva/IVAX Merger; Closing Scheduled for January 26, 2006|
Jerusalem, Israel and Miami, Florida, January 23, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and IVAX Corporation (AMEX: IVX) announced today that the U.S. Federal Trade Commission ("FTC") has accepted the proposed consent order for public comment and granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.